Analysts at Morgan Stanley (MS) upgraded Laboratory Corp. of America Holdings (LH) from ‘Underweight‘ to ‘Overweight‘ in a research report issued to clients on Monday. The name was also raised to $127 from $110 at Mizuho. The move comes on a big volume too with the issue currently trading more than 1.6 million shares, compared to the average volume of 1.4 million shares.
On valuation measures, Laboratory Corp. of America Holdings stock it is trading at a forward P/E multiple of 15.12x, and at a multiple of 20.58x this year’s estimated earnings.
The T-twelve-month revenue at Laboratory Corp. of America Holdings is $5.94 billion. LH ‘s ROE for the same period is 19.33%.
Shares of the $10.37 billion market cap company are up 30.63% year-over-year, and 12.22% year-to-date.
LH, currently with a median Wall Street price target of $130.00 and a high target of $141.00, rose $1.59 to $122.67 in recent trading.
The chart below shows where the equity has traded over the past 52-weeks.
Colgate-Palmolive Co. (CL) was upgraded from ‘Neutral‘ to ‘Buy‘ at Citigroup (C).
Shares have traded today between $70.46 and $71.01 with the price of the stock fluctuating between $61.58 to $71.31 over the last 52 weeks.
Colgate-Palmolive Co. shares are currently changing hands at 29.94x this year’s forecasted earnings, compared to the industry’s 23.10x earnings multiple. Ticker has a t-12 price/sales ratio of 3.70. EPS for the same period registers at $2.36.
Shares of CL have gained $0.43 to $70.67 in mid-day trading on Monday, giving it a market cap of roughly $64.40 billion. The stock traded as high as $71.31 in December 24, 2014.
The Boeing Company (BA) was reiterated a ‘Buy’ by Stifel analysts on Monday. The broker also raised its price target on the stock to $175 from $160.
On valuation measures, The Boeing Company shares are currently priced at 20.95x this year’s forecasted earnings compared to the industry’s -13.00x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.46 and 16.85, respectively. Price/Sales for the same period is 1.23 while EPS is $7.38. Currently there are 13 analysts that rate BA a ‘Buy’, 8 rate it a ‘Hold’. 1 analyst rates it a ‘Sell’. BA has a median Wall Street price target of $157.50 with a high target of $196.00.
In the past 52 weeks, shares of Chicago, Illinois-based company have traded between a low of $116.32 and a high of $158.83 and are now at $154.62. Shares are up 25.11% year-over-yea, and 22.55% year-to-date.
3D Systems Corporation (DDD) was reiterated as ‘Buy’ with a $40 from $44 price target on Monday by Needham.
3D Systems Corporation, currently valued at $3.46B, has a median Wall Street price target of $36.00 with a high target of $66.00. Approximately 1.49M shares have already changed hands, compared to the stock’s average daily volume of 2.92M.
In the past 52 weeks, shares of the 3D printing provider have traded between a low of $27.00 and a high of $79.77 with the 50-day MA and 200-day MA located at $30.27 and $38.69 levels, respectively. Additionally, shares of DDD trade at a P/E ratio of 2.00 and have a Relative Strength Index (RSI) and MACD indicator of 53.67 and +0.62, respectively.
DDD currently prints a one year loss of about 62%, and a year-to-date loss of around 5.50%.
Tesaro, Inc. (TSRO) rating of ‘Buy’ was reiterated today at Citigroup (C) with a price target increase of $79 from $51 (versus a $44.20 previous close).
TSRO shares recently gained $6.58 to $50.78. In the past 52 weeks, shares of Waltham, Massachusetts-based oncology-focused biopharmaceutical company have traded between a low of $22.15 and a high of $50.97. Shares are up 38.25% year-over-year, and 18.85% year-to-date.